Crescentic Glomerulonephritis Associated with MPO-ANCA during Propylthiouracil Treatment : a Case report and Literatures Review

Main Article Content

Nirut Suwan

Abstract

          ANCA-related crescentic glomerulonephritis is an uncommon illness. It has become evident that ANCA, predominant of the P-ANCA type, can be detected in patients association with anti-thyroid (MPO-ANCA) during propylthiouracil (PTU) treatment. Although the serum creatinine level gradually decreased after cessation of PTU and immunosuppressive treatment, irreversible renal dysfunction persisted. Because of the widespread use of anti-thyroid medication, patients treated with PTU should be placed under vigilant observation by monitoring their urinalysis and serum creatinine level.


 

Article Details

How to Cite
Suwan, N. (2024). Crescentic Glomerulonephritis Associated with MPO-ANCA during Propylthiouracil Treatment : a Case report and Literatures Review. Maharat Nakhon Ratchasima Hospital Journal, 31(1), 47–54. retrieved from https://he04.tci-thaijo.org/index.php/MNRHJ/article/view/1967
Section
Case Report

References

Cooper DS, Drug Therapy: Anithyroid Drugs. N Engl J Med 2005; 352: 905-17.

Jennette JC, Falk RJ. Small vessei vasculitis. N Engl J Med 1997; 337: 1512-23.

Vogt BA, Youngi K, Jennette IC, Falk RJ,Burke BA. Sinaiko A. Anti-neutrophil cytoplasmic autoantibodypositive cresentic glomerulonephritis as a complication of treatment with propylthiouracil in children. Pediatr 1994; 124: 986-8.

Dolman KM, Gans ROB, Vervaat TJ, Zevenbergen G, Maingay D, Kikkels RE, etal. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-2.

Davies DJ, Moran JE, Niall JF, Ryan GB.Segmental necrotising glomerulonephritis with antineutrophil antibody: possible arbovinus aetiology? Br Med 1982;285;285: 606.

Hall JB, Wadham BM, Wood CJ, Ashton V, Adam WR. Vasculitis and glomerulonephritis: a subgroup with an antineutrophil cytoplasmic antibody. Aust N J Med 1984; 14: 277-8.

Van der Woude, FJ, Rasmussen N, Lobatto S. Wiik A, Permin H, Van Es, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 425-9.

Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N EngI J Med 1988; 318: 1651-7.

Hoffman GS, Specks U. Antineutrophil cynoplasmic antibodies. Arthritis Rheum 1998; 41: 1521-37.

Franssen CFM, Stegeman CA, Kallenberg CGM, Gans ROB, de Jong PE, Hoomije SJ, et al. Antiproteinasc 3- and antimyeloperoxidasc-associated vasculitis. Kidney Int 2000; 57: 2195-206.

Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993; 91: 1-12.

Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337: 1512-23.

Lie JT. Aortic and extracranial large vesseI giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995; 24:422-31.

Gail SK, Claire WH, Joseph G, Randi YL, Anthony SF, Menachem R, et al. Ann Intern Med 1994; 120: 919-29.

Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 488-98.

Hoffman GS, Specks U.Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998; 41: 1521-37.

Niles JL, Pan GL, Collins AB, Shannon T, Skates S, Fienberg R, et al. Antigen-specific radioimmunoassays for anti-neutrophil cytoplasmic antibodies in the diagnosis of rapidly progressive glomerulonephritis. I Am Soc Nephrol 1991; 2: 27-36.

Guillevin L, Cohen P, Gayraud M, Lhofe F, Jarrouse B, Casassus P. Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine 1999; 78: 26-37.

Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP,et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthris Rheum 1990; 33: 1094-100.

Tervaert JW, Kallenberg CGM. Anti-myeloperoxidase antibodies in Churg-Strauss syndrome. J Neurol 1993; 240: 449-50.

Dillon MJ, Ansell BM. Vasculitis in children and adolescents. Rheum Dis Clin North Am 1995; 21:1115-36.

Irvine AD, Bruce IN, Walsh MY, Bingham EA. Microscopic polyangiitis: delineation of a cutaneous-limited variant associated with antimyeloperoxidase auto antibody. Arch Dermatol 1997; 133: 474-7.

Langford CA. Treatment of polyarteritis nodosa, microscopic polyangritis, and Churg-Strauss syndrome: where do we stand? Arthritis Rheum 2001; 44: 508-12.

Choi HK, Merkel PA, Walker AM, Niles JL. Drug-asso-ciated neutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyel-operoxidase antibodies. Arthritis Rheum 2000; 43:405-13.

Dolman KM, Gans ROB, Vervaat TJ, Zevenberger G,. Maingay D, Nikkels RE, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342: 651-2.

Gunton JE, Stiel J, Clitton-Bligh P, Winshurst E, Mc~Elduff A. Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication. Eur J Endocrinol 2000; 142: 587.

Otsuka S, Kinebuchi A, Tabata H, Yamakage A, Yamazaki S. Myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis following propylthiouracil therapy. Br J Dermatol 2000; 142: 828-30.

Carrasco MD, Riera C, Clotet B, Grifol M, Foz M. Cutancous vasculitis associated with propylthiouracil therapy. Arch Intern Med 1987; 147: 1677.

Jiang X, Khursigara G, Rubin RI. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266: 810-3.

von Schmiedeberg S, Goebel C, Gleichmann E, Uetrecht J. Neutrophils and drug metabolism. Science 1995; 268: 585-6.

Lee E, Katsura H, Miki Y, Kariya K. Mechanism of inactivation of myeloperoxidase by propy///thiouracil. Biochem Pharmacol 1990; 39: 1467-71.

Yu F, Chen M, Gao Y, Wang Sx, Zou Wz. Clinical and Pathological Features of Renal Involvement in Propyithiouracil-Associated ANCA-Positive Vascutis 2007: 49: 607-14.

Faical J, Mohamed A, Richard J. Myeloperoxidase- antineutrophil cyroplasmic antibody-posive crescentic glomerulonephritis associated with benzylthiouracil therapy. Nephrol Dial Transplant 2003; 2421-3.

Jennette JC, Falk RJ. Small-Vessel Vasculis. N Engl J Med 1997; 337: 1512-23.